30 assets in Bipolar I Disorder

Therapeutic assets addressing Bipolar I Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lurasidone Bipolar I Disorder	Massachusetts General Hospital	P4	BBB (79)
Escitalopram Bipolar I Disorder	Massachusetts General Hospital	P4	BBB (77)
Lithium, Elemental Bipolar I Disorder	Alzamend Neuro, Inc.	P4	BBB (77)
Olanzapine Bipolar I Disorder	Alkermes, Inc.	P4	BBB (75)
Cariprazine Bipolar I Disorder	Pakistan Institute of Medical Sciences	P4	BBB (73)
Iloperidone Bipolar I Disorder	Vanda Pharmaceuticals	P4	BBB (73)
Lamotrigine Bipolar I Disorder	Bristol-Myers Squibb	P4	BBB (73)
Valproic Acid Bipolar I Disorder	Bristol-Myers Squibb	P4	BBB (72)
Quetiapine Bipolar I Disorder	Massachusetts General Hospital	P4	BB (70)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Bipolar I Disorder	Joshua Rosenblat	P4	BB (68)
Dexmedetomidine Bipolar I Disorder	BioXcel Therapeutics Inc	P3	BB (68)
Risperidone Bipolar I Disorder	Pakistan Institute of Medical Sciences	P4	BB (68)
Clozapine Bipolar I Disorder	University of Texas Southwestern Medical Center	P4	BB (65)
Naltrexone Bipolar I Disorder	Mayo Clinic	P4	B (62)
Samidorphan Bipolar I Disorder	Alkermes, Inc.	P3	B (62)
Semaglutide Bipolar I Disorder	Mayo Clinic	P4	B (62)
Midazolam Bipolar I Disorder	Joshua Rosenblat	P2	B (61)
Endoxifen Enteric-Coated Bipolar I Disorder	Jina Pharmaceuticals Inc.	P3	B (60)
Karxt Bipolar I Disorder	Bristol-Myers Squibb	P3	B (60)
Abbv-932 Bipolar I Disorder	AbbVie	P2	B (57)
Acetylcysteine Bipolar I Disorder	Medical University of South Carolina	P2	B (57)
Encukalner Bipolar I Disorder	Xenon Pharmaceuticals Inc.	P3	B (57)
Gabapentin Bipolar I Disorder	Medical University of South Carolina	P2	B (57)
Icalcaprant Bipolar I Disorder	AbbVie	P2	CCC (53)
lb-102 Bipolar I Disorder	LB Pharmaceuticals Inc.	P2	CCC (53)
Nbi-1117568 Bipolar I Disorder	Neurocrine Biosciences	P2	CCC (53)
Rap-219 Bipolar I Disorder	Rapport Therapeutics Inc.	P2	CCC (53)
Elpipodect Bipolar I Disorder	Merck Sharp & Dohme LLC	P1	CC (44)
Vhx-896 Bipolar I Disorder	Vanda Pharmaceuticals	P1	CC (44)
Latozinemab Bipolar I Disorder	Alzamend Neuro, Inc.	P1/2	CC (41)